Navigation Links
Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
Date:8/27/2007

-Acquisition of Pacific Pharma Technologies Brings Proprietary Artificial Intelligence-Based Drug Discovery Platform and Novel Drug Candidates to

Upstream-

-Initial Compounds Demonstrate Promising In Vitro Activity Against Devastating Parasitic Diseases Affecting 300 Million People Worldwide-

VANCOUVER, B.C., Aug. 27 /PRNewswire-FirstCall/ -- Upstream Biosciences Inc. (OTC Bulletin Board: UPBS) today announced it has completed the acquisition of Pacific Pharma Technologies Inc., an early stage biopharmaceutical company with a proprietary technology platform that combines artificial intelligence, advanced computational methods and chemical diversity techniques to discover new drugs. This technology has already generated novel compounds that in laboratory studies demonstrate both human and veterinary potential against major tropical parasitic diseases.

"This acquisition significantly broadens our strategic focus and provides Upstream with important new capabilities," said Joel L. Bellenson, Chief Executive Officer of Upstream. "We believe the innovative technology platform pioneered by Pacific Pharma may have substantial commercial potential in a number of therapeutic areas and it fits well with our existing core competencies in computational-based approaches to biomarker identification. Pacific Pharma has also generated novel compounds that have exhibited activity against targets relevant to cancer, the focus of our biomarker programs."

In screening studies in vitro, Pacific Pharma's lead compounds have demonstrated encouraging signs of efficacy against leishmaniasis and African sleeping sickness (trypanosomiasis). These parasites, which belong to a family of protozoa species that include Chagas disease and malaria, infect millions of individuals in Africa, South Asia and South America. Current treatments are often toxic, ineffective, inconvenient and expensive. In addition, recent reports document
'/>"/>

SOURCE Upstream Biosciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
4. Neurocrine Biosciences Announces New Research Studies Presented at APSS Reveal Significant Under-Diagnosis of Insomnia
5. Hana Biosciences Presents Data On Two Programs At the American Society of Clinical Oncology Annual Meeting
6. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
7. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
8. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
9. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
10. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
11. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ("Galmed"), ... and commercialization of a once-daily, oral therapy for ... today announced financial results for the 12 months ... 2014 Highlights: , Hosted a key opinion ... Rohit Loomba, MD, MHSc., who discussed the topic ...
(Date:3/31/2015)... March 31, 2015   Unique Pharmaceuticals , a ... complete and the company has initiated sterile compounding operations ... goal as a company is to meet and exceed ... . "Meeting the new regulations is validation of our ... the future of our industry, investing in its continued ...
(Date:3/31/2015)... , March 31, 2015 ... today announced a strategic partnership with Medidata ... for clinical research in life sciences. Offering therapeutic ... CRO has deployed Medidata,s electronic data capture (EDC), ... Biorasi,s Phase I through IV global clinical trial ...
Breaking Medicine Technology:Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 2Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 3Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 4Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 5Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 6Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 7Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 8Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 2Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 4
... Oct. 3, 2011 Varian Medical Systems (NYSE: ... senior managers to support the company,s ongoing growth and ... Vice President for the company, has been named Chief ... development, production, promotion, and sale of all Varian products ...
...   PLC Medical Systems, Inc. (OTC: PLCSF) today announced ... , October 6, 2011TIME: , 11:00 AM ... "register/ watch event now" button.This will be a live, ... the company questions in real-time both in the presentation ...
Cached Medicine Technology:Varian Medical Systems Announces New Management Positions 2Varian Medical Systems Announces New Management Positions 3Varian Medical Systems Announces New Management Positions 4PLC Medical Systems to Present Webcast Live, at RetailInvestorConferences.com on October 6th 2
(Date:3/31/2015)... (PRWEB) March 31, 2015 Dr. Poneh Ghasri, ... offer patients valuable savings through new Spring specials. Dr. Poneh ... the holiday celebration this year by taking advantage of discounted ... , "Spring brings together friends and loved ones that want ... We are pleased to offer solutions for a great looking ...
(Date:3/31/2015)... Diane Blackburn-Zambetti is the Director of ... Research Foundation (Meso Foundation). Blackburn-Zambetti will present an ... the BoRit Asbestos Superfund Citizen Advisory Group Meeting ... discuss anatomy, six types of asbestos, asbestos products, ... prevention and proper communication with your healthcare provider. ...
(Date:3/31/2015)... A team of Italian scientists is using ... into mesothelioma cancer cells. Surviving Mesothelioma has just posted ... Click here to read it now. , ... the spice turmeric, has limited value as a cancer ... Università di Napoli Federico II are getting around the ...
(Date:3/31/2015)... MO (PRWEB) March 31, 2015 The ... 2015 from 5:00 to 8:00 pm at the SpringHill Suites ... hospitals, clinics and groups with career opportunities will be attending ... will enjoy free hors d’oeuvres and raffle prize drawings. , ... says “Denver is an ideal location to hold a career ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 The KIND LED K5 ... yields in the tightest of spaces. These large yields are due ... the packaged arrays. The KIND LED K5 grow lights use a ... efficiently amongst the 2 CM aluminum circuit boards that are the ... the KIND LED K35 lights are immense. The KIND LED K5 ...
Breaking Medicine News(10 mins):Health News:West Hollywood Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering Various Special Offers Just in Time for Spring 2Health News:Mesothelioma Foundation to speak at BoRit Asbestos Superfund Citizen Advisory Group Meeting 2Health News:New Research Reveals Novel Delivery Method for Potential Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:PracticeMatch to Host Physician Career Fair at SpringHill Suites Denver on April 8, 2015 2Health News:PracticeMatch to Host Physician Career Fair at SpringHill Suites Denver on April 8, 2015 3Health News:LED SuperNova Grow Box by SuperCloset Now Available with the KIND LED K5 Series 2
... their health are more successful at beating one of ... The study, funded by the federal Agency for Healthcare ... hypertension an electronic personal health record that enables them ... eat in their medical record and e-mail their physicians ...
... Very young brains process memories of fear differently than more ... Feb. 6 issue of The Journal of Neuroscience . ... fear is stored and unlearned, and introduces new thinking on ... important paper raises questions that are the tip of the ...
... and within countries, researcher notes , , WEDNESDAY, Feb. ... and within European countries in the rates of stroke ... example, rates of such deaths in several countries -- ... much as seven to 14 times higher than in ...
... Baycap Inc. ("Baycap"),today announced that it has donated ... Coordt and Peter Metropoulos, directors at Baycap,are Mira Costa ... the school with top of the line equipment and ... equipment will allow Mira Costa to add a third ...
... Society for Neuroscience (SfN), the worlds largest organization ... and nervous system, today released a new document ... but not limited to, those who face,intimidation, harassment, ... The,document, Best Practices for Protecting Researchers and ...
... Feb. 6 MarketResearch.com, a leading online,provider ... of key,findings on the global market for ... research publisher MarketStrat, Inc., Making available ... Specialty Medical Beds Therapeutic Surfaces Worldwide,MarketResearch.com provides ...
Cached Medicine News:Health News:Impact of electronic personal health record on hypertension under study 2Health News:Impact of electronic personal health record on hypertension under study 3Health News:Impact of electronic personal health record on hypertension under study 4Health News:Very young found to process fear memories in unique way 2Health News:Death Rates From Cardiovascular Causes Vary Widely Across Europe 2Health News:SfN releases 'Best Practices for Protecting Researchers and Research' 2Health News:MarketResearch.com Distributes Key Findings on Global Specialty Medical Beds and Therapeutic Surfaces Market 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: